Genomics

Dataset Information

0

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in Acute Myeloid Leukemia


ABSTRACT: Purpose: Compare transcriptional changes between drug treated (gilteritinib, TP-0903) and vehicle in acute myeloid leukemia xenografts. Methods: FLT3-ITD+ MOLM13-RES-Luc+ (MOLM13 cells with a D835Y mutation generating a resistant phenotype) AML cells were xenografted into NSG mice. Mice were randomized according to bioluminescence imaging, and treatment of FLT3 tyrosine kinase inhibitor (gilteritinib, 30 mg/kg, once daily for 5 days/week) was started on day 13 post-tail vein injection. At study end point, mice were humanely euthanized and bone marrow was collected. AML cells (human CD45+) were isolated, and ATAC-seq was performed on HiSeq 4000, total RNA. Sequencing reads were aligned and analyzed for differential gene expression of treatment vs vehicle cohorts. Results: The analysis revealed the chromatin accessibility changes induced by gilteritinib in MOLM13-RES AML xenograft model.

ORGANISM(S): Homo sapiens

PROVIDER: GSE179421 | GEO | 2021/07/07

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-07-22 | GSE180180 | GEO
2021-07-22 | GSE180181 | GEO
2024-06-14 | GSE244855 | GEO
2022-08-25 | PXD034080 | Pride
2022-08-25 | PXD034081 | Pride
2022-08-09 | GSE210617 | GEO
2022-07-07 | GSE199333 | GEO
2022-09-21 | GSE185519 | GEO
2022-08-25 | PXD023123 | Pride
2022-08-25 | PXD023125 | Pride